Primary study · included by 1 review
Langerhans cell histiocytosis oral lesions in pediatric patients.
Pavan 2023 · Pavan Verónica H, Fernández de Preliasco Virginia, Ienco Melisa, et al. · Acta odontologica latinoamericana : AOL · 2023
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified) | Proportion 0.097 [0.076, 0.119] | 11 studies · 1806 participants | GRADE not reported |
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified) | Proportion 0.205 [0.144, 0.267] | 16 studies · 2052 participants | Low |
Prevalence of oral manifestations Oral manifestations (oral mucosa and jaw bone lesions) vs Not applicable · At diagnosis | Prevalence (%) 14.86 [11.80, 18.58] | 16 studies · 2052 participants | Low |
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified) | Proportion 0.1057 | 11 studies · 1806 participants | GRADE not reported |
1 including review in total.